1. Osteoarthritis Pain - Pipeline Review, H1 2017 Published: May 2017 Single User PDF: US$ 2000 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any.sales@reportsandreports.com 1 © ReportsnReports.com / Contact sales@reportsandreports.com

2. Osteoarthritis Pain - Pipeline Review, H1 2017 Osteoarthritis Pain Pipeline Market Reviews of Therapeutics by Worldwide Companies, Universities and Research Institutes, H1 2017 report provides comprehensive information on the therapeutics under development for Osteoarthritis Pain, complete with analysis by stage of development, drug target, route of administration and molecule type. The Osteoarthritis Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis Pain and features dormant and discontinued projects. The report reviews key players involved in the therapeutic development for Osteoarthritis Pain and special features on late-stage and discontinued projects. Access Complete Report at: http://www.reportsnreports.com/reports/992889-osteoarthritis-pain- pipeline-review-h1-2017.html.http://www.reportsnreports.com/reports/992889-osteoarthritis-pain- pipeline-review-h1-2017.html Offers from 10th May 2017 to 2nd June 2017 All reports priced >=1,000 – 20% Discount – Single User ; 25% Discount – Global Site License. Buy 2 Reports Get 1 Report Free Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. sales@reportsandreports.com 2 © ReportsnReports.com / Contact sales@reportsandreports.com

3. Osteoarthritis Pain - Pipeline Review, H1 2017 Osteoarthritis pain is the most common symptom associated with osteoarthritis which causes disruption of the cartilage. This further leads to rubbing of the bones against each other stimulating pain. The predisposing factors are age, joint injury, obesity and heredity. It may be diagnosed by physical examination and MRI and X-ray imaging. The condition may be controlled by weight control, exercise and medication. Osteoarthritis Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The report is built using data and information sourced from company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Inquire for Discount http://www.reportsnreports.com/contacts/discount.aspx?name=992889.http://www.reportsnreports.com/contacts/discount.aspx?name=992889 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. sales@reportsandreports.com 3© ReportsnReports.com / Contact sales@reportsandreports.com

4. Osteoarthritis Pain - Pipeline Review, H1 2017 Scope The pipeline guide provides a snapshot of the global therapeutic landscape of Osteoarthritis Pain (Central Nervous System). The pipeline guide reviews pipeline therapeutics for Osteoarthritis Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The pipeline guide reviews key companies involved in Osteoarthritis Pain (Central Nervous System) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Osteoarthritis Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Buy a Copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=992889.http://www.reportsnreports.com/purchase.aspx?name=992889 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. sales@reportsandreports.com 4© ReportsnReports.com / Contact sales@reportsandreports.com

5. Osteoarthritis Pain - Pipeline Review, H1 2017 Companies Involved in Therapeutics Development AbbVie Inc 30, Addex Therapeutics Ltd,Allergan Plc,Ampio Pharmaceuticals Inc,Antibe Therapeutics Inc,Aralez Pharmaceuticals Inc,Arena Pharmaceuticals Inc,Array BioPharma Inc,Astellas Pharma Inc,Axsome Therapeutics Inc,BELLUS Health Inc,Boehringer Ingelheim GmbH,Cara Therapeutics Inc,Chromocell Corp,Eli Lilly and Company,Elite Pharmaceuticals Inc,Eupraxia Pharmaceuticals Inc,Flexion Therapeutics Inc,Genzyme Corp,GlaxoSmithKline Plc,Grunenthal GmbH,Iroko Pharmaceuticals LLC,Marina Biotech Inc,Medestea Research & Production SpA,MedImmune LLC,Merck & Co Inc,Nuvo Pharmaceuticals Inc,Ono Pharmaceutical Co Ltd,Pfizer Inc,Phosphagenics Ltd,ProteoThera Inc,pSivida Corp,Purdue Pharma LP,Regeneron Pharmaceuticals Inc,Rottapharm Biotech Srl,Shionogi & Co Ltd,Symic Biomedical Inc,Taiwan Liposome Company Ltd,Vertex Pharmaceuticals Inc,Zynerba Pharmaceuticals Inc. Buy a Copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=992889.http://www.reportsnreports.com/purchase.aspx?name=992889 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. sales@reportsandreports.com 5 © ReportsnReports.com / Contact sales@reportsandreports.com5

6. Osteoarthritis Pain - Pipeline Review, H1 2017 List of Tables 12.Number of Products under Development by Companies, H1 2017 3.Number of Products by Stage and Target, H1 2017 4.Number of Products by Stage and Mechanism of Action, H1 2017 5.Number of Products by Stage and Route of Administration, H1 2017 6.Number of Products by Stage and Molecule Type, H1 2017 and More… List of Figures 1.Number of Products under Development for Osteoarthritis Pain, H1 2017 2.Number of Products under Development by Companies, H1 2017 3.Number of Products under Development by Universities/Institutes, H1 2017 4.Number of Products by Routes of Administration, H1 2017 5.Number of Products by Stage and Routes of Administration, H1 2017 6.Number of Products by Molecule Types, H1 2017 7.and More….Number of Products under Development for Osteoarthritis Pain, H1 2017 Buy a Copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=992889.http://www.reportsnreports.com/purchase.aspx?name=992889 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. sales@reportsandreports.com 6 © ReportsnReports.com / Contact sales@reportsandreports.com6

7. About ReportsnReports ReportsnReports.comReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Contact: Ritesh Tiwari Maharashtra, India. Tel: +1-888-391-5441 sales@reportsnreports.com 7© ReportsnReports.com / Contact sales@reportsandreports.com